ConductScience.org, home

Paper17515386

Diffusion-weighted MRI in the body: applications and challenges in oncology.

Koh DM and 1 other. AJR Am J Roentgenol, 2007. Cited by 1,510 papers, by iCite.

Cite this record

ConductScience Library. Diffusion-weighted MRI in the body: applications and challenges in oncology. Papers, record 17515386. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17515386

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diffusion-weighted MRI in the body: applications and challenges in oncology.
PubMed
Journal
AJR Am J Roentgenol
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
1,510
iCite
Relative citation ratio, by iCite
50
iCite
Revised in PubMed
2022-03-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Koh DMDow-Mu
2Collins DJDavid J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diffusion Magnetic Resonance ImagingMajor topic
Image EnhancementMajor topic
Image Interpretation, Computer-AssistedMajor topic
Medical OncologyMajor topic
NeoplasmsMajor topic
Whole Body ImagingMajor topic
Adult
Humans
Male
Prognosis

Source PubMed

Download CSV of topics

Trials5

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03163316The Role of Magnetic Resonance Imaging in Assessment of Axillary Lymph Nodes Metastasis in Breast Cancer Patients.BackgroundClinicalTrials.gov
NCT03961646Evaluation of the FOCUS Diffusion's Added Clinical Value Compared to Conventional MRIBackgroundClinicalTrials.gov
NCT05097105Role of Diffusion -Weighted MRI in Evaluation of Urinary Bladder MassesBackgroundClinicalTrials.gov
NCT05384535Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk CohortBackgroundClinicalTrials.gov
NCT05550090Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBCResultsClinicalTrials.gov

Download CSV of trials

Cited by716

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,510 citations.

PMIDTitleJournalYearIn PapersSource
42961728High Spatial Resolution 23Na-MRI for Ischemic Brain Injury Detection.Transl Stroke Res2026https://conductscience.org/library/papers/42961728PubMed
42919290Three-dimensional multimodal fractal dynamics integrating spatial metabolism, cytoarchitecture, and perfusion for preoperative prediction of microvascular invasion in colorectal liver metastases.J Transl Med2026https://conductscience.org/library/papers/42919290PubMed
42898154
An interim analysis of acute treatment adverse events and patient reported quality of life for functional imaging guided salivary gland sparing radiation therapy using diffusion-weighted magnetic resonance imaging.
Phys Imaging Radiat Oncol2026https://conductscience.org/library/papers/42898154PubMed
42804146A preliminary evaluation of chest magnetic resonance imaging in adult patients with non-cystic fibrosis bronchiectasis.Radiol Med2026https://conductscience.org/library/papers/42804146PubMed
42758291Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.Eur Radiol2026https://conductscience.org/library/papers/42758291PubMed
42758286Reply to the Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.Eur Radiol2026https://conductscience.org/library/papers/42758286PubMed
42755601MRI-derived features reveal recurrence heterogeneity in VI-RADS 2 non-muscle-invasive bladder cancer.Front Oncol2026https://conductscience.org/library/papers/42755601PubMed
42732951Multi-pool Model-based Amide Proton Transfer Imaging for Tumor Characterization and Risk Stratification in Endometrial Carcinoma.Magn Reson Med Sci2026https://conductscience.org/library/papers/42732951PubMed
42696114Integrated model of MRI biomarkers and clinical factors for predicting pathologic response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.Abdom Radiol (NY)2026https://conductscience.org/library/papers/42696114PubMed
42599582
Diffusion-weighted magnetic resonance imaging as a promising technique for detection and follow-up of liver metastases from neuroendocrine tumors: a retrospective and prospective study from the NETTARE task force.
J Endocrinol Invest2026https://conductscience.org/library/papers/42599582PubMed
42564379Corticosteroid-responsive portal lymphadenopathy mimicking malignant progression induced by furmonertinib in EGFR-mutated NSCLC: a case report.Front Pharmacol2026https://conductscience.org/library/papers/42564379PubMed
42437229Role of Whole-Body Magnetic Resonance Imaging in Detecting Metastasis in Patients With Known Cancer.Cureus2026https://conductscience.org/library/papers/42437229PubMed
42433582Impact of deep-learning image reconstruction on multiplexed sensitivity encoding diffusion-weighted imaging in the female pelvis.Quant Imaging Med Surg2026https://conductscience.org/library/papers/42433582PubMed
42412308Deep learning reconstruction-applied PROPELLER diffusion-weighted imaging in uterine malignancies: a comparison study with MUSE.Jpn J Radiol2026https://conductscience.org/library/papers/42412308PubMed
42381110Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [68Ga]GaPSMA-PET/CT for [177Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).Cancer Imaging2026https://conductscience.org/library/papers/42381110PubMed
42243941Apparent diffusion coefficient and kurtosis parameters show early response to anti-angiogenic therapy in patients with colorectal liver metastases.Cancer Imaging2026https://conductscience.org/library/papers/42243941PubMed
42216654Collaborative Reconstruction of PROPELLER-EPI Data Using POCSMUSE (CORPUSE) for High-Fidelity Diffusion MRI.Magn Reson Med2026https://conductscience.org/library/papers/42216654PubMed
42209675Viscoelastic profiling of rare pediatric extracranial tumors using multifrequency MR elastography: a pilot study.Sci Rep2026https://conductscience.org/library/papers/42209675PubMed
42193007Radiological Features of Human Papillomavirus (HPV)-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma (OPSCC)-Considerations for Multimodal Analysis.Cancers (Basel)2026https://conductscience.org/library/papers/42193007PubMed
42181386Subtle Enhancing Mural Thickening With Diffusion Restriction: An Early MRI Clue to Malignant Transformation in Ovarian Dermoid Cyst.Cureus2026https://conductscience.org/library/papers/42181386PubMed

See all 716 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17515386

GET https://conductscience.org/api/papers/v1/17515386/cited_by?page=2